跳至主要内容
临床试验/IRCT2017061113739N9
IRCT2017061113739N9已完成1 期

Evaluation of the effect of Glucuronic acid on processing of breast cancer disease

Vice-Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65 years 至 35 years(—)
性别
Female

入选标准

  • Inclusion Criteria: 30-60 years old patients, Diagnosed with breast cancer according to American College of oncology Diagnostic Criteria after the initial visit by a specialist in cancer surgery and parameters CEA, CA15.3, CBC and sonography, Each patient must sign written informed consent.

排除标准

  • History of fever and Infectious diseases, Positive pregnancy test or Lactation, Other collagen- vascular and auto immune diseases, Patients have enrolled another clinical trial study within last 4 weeks, Other concomitant diseases (Hepatic, renal, haematological, gastrointestinal, endocrine, cardiovascular, pulmonary, neurological or cerebral disease).

研究者

发起方
Vice-Chancellor for Research, Tehran University of Medical Sciences

相似试验